JFG
CBAY

Jefferies Financial Group’s Cymabay Therapeutics CBAY Stock Holding History

Jefferies Financial Group’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,800
Closed -$420K – 2140
2023
Q4 		$420K Buy
+17,800
New +$317K ﹤0.01% 1283

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jefferies Financial Group's CBAY Position: Q1 2024 in Review

Jefferies Financial Group sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 586,298 shares — an estimated $13.8M sold.

Jefferies Financial Group first reported a position in CBAY in Q1 2023 and held it in 2 quarters. The position peaked at $13.8M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Jefferies Financial Group reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 586,298 Cymabay Therapeutics shares in Q1 2024, an estimated $13.8M.
  • Jefferies Financial Group first reported a position in Cymabay Therapeutics in Q1 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Cymabay Therapeutics position peaked at $13.8M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.